These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25423436)

  • 1. A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients.
    Carter BL; Damer KM; Walroth TA; Buening NR; Foster DR; Sood R
    J Burn Care Res; 2015; 36(6):641-50. PubMed ID: 25423436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified dosing and monitoring of vancomycin for the burn care clinician.
    Rice TL
    Burns; 1992 Oct; 18(5):355-61. PubMed ID: 1445623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of vancomycin dosing and subsequent serum concentrations in pediatric patients.
    Eiland LS; English TM; Eiland EH
    Ann Pharmacother; 2011 May; 45(5):582-9. PubMed ID: 21521865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered vancomycin dose vs. serum concentration relationship in burn patients.
    Garrelts JC; Peterie JD
    Clin Pharmacol Ther; 1988 Jul; 44(1):9-13. PubMed ID: 3292106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetic/pharmacodynamic rationale for administering vancomycin via continuous infusion.
    Waineo MF; Kuhn TC; Brown DL
    J Clin Pharm Ther; 2015 Jun; 40(3):259-65. PubMed ID: 25865426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries.
    Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K
    J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of an empiric vancomycin dosing algorithm for improved target concentration attainment in patients with thermal injury.
    Hill DM; Velamuri SR; Lanfranco J; Romero Legro I; Sinclair SE; Hickerson WL
    Burns; 2019 Mar; 45(2):423-432. PubMed ID: 30340863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing initial vancomycin dosing in burn patients.
    Elligsen M; Walker SA; Walker SE; Simor A
    Burns; 2011 May; 37(3):406-14. PubMed ID: 21095062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individualized dosing of vancomycin in geriatric patients.
    Suchánková H; Lečbychová K; Strojil J; Fürst T
    Epidemiol Mikrobiol Imunol; 2020; 69(4):172-180. PubMed ID: 33445941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study evaluating tobramycin pharmacokinetics and optimal once daily dosing in burn patients.
    Lee C; Walker SAN; Walker SE; Seto W; Simor A; Jeschke M
    Burns; 2017 Dec; 43(8):1766-1774. PubMed ID: 28647460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of vancomycin dosing regimens in preterm and term neonates using Monte Carlo simulations.
    Mehrotra N; Tang L; Phelps SJ; Meibohm B
    Pharmacotherapy; 2012 May; 32(5):408-19. PubMed ID: 22488303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Quasi-Experiment To Study the Impact of Vancomycin Area under the Concentration-Time Curve-Guided Dosing on Vancomycin-Associated Nephrotoxicity.
    Finch NA; Zasowski EJ; Murray KP; Mynatt RP; Zhao JJ; Yost R; Pogue JM; Rybak MJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin pharmacokinetics in neonates and infants: a retrospective evaluation.
    Asbury WH; Darsey EH; Rose WB; Murphy JE; Buffington DE; Capers CC
    Ann Pharmacother; 1993 Apr; 27(4):490-6. PubMed ID: 8477127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of vancomycin pharmacokinetics in neonates to develop practical initial dosing recommendations.
    Kim J; Walker SA; Iaboni DC; Walker SE; Elligsen M; Dunn MS; Allen VG; Simor A
    Antimicrob Agents Chemother; 2014 May; 58(5):2830-40. PubMed ID: 24614381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics in patients with severe burn injuries.
    Dolton M; Xu H; Cheong E; Maitz P; Kennedy P; Gottlieb T; Buono E; McLachlan AJ
    Burns; 2010 Jun; 36(4):469-76. PubMed ID: 19875238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
    Truong J; Levkovich BJ; Padiglione AA
    Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Individualised vancomycin doses for paediatric burn patients to achieve PK/PD targets.
    Gomez DS; Campos EV; de Azevedo RP; Silva JM; Ferreira MC; Sanches-Giraud C; Silva CV; Santos SR
    Burns; 2013 May; 39(3):445-50. PubMed ID: 22867735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Multicenter, Retrospective Outcome Analysis of Vancomycin Area Under the Curve versus Trough-Based Dosing Strategies in Patients with Burn OR Inhalational Injuries (MONITOR).
    Santos R; Boyd AN; Walroth TA; Hall A; King J; Ahiskali A; Walter E; Neumann N; Curry D; Hoyte B; Thomas W; Adams B; Tran N; Gleason VM; Drabick Z; DeWitt A; Suarez J; Prazak AMB; Disney KA; Hill D
    J Burn Care Res; 2024 Jun; ():. PubMed ID: 38900835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.